Applovin Corporation Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter.
equity_securities_no_fv_impairment_cumulative| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $28.00M | $48.40M | $78.00M | $0.00 |
| QoQ Change | — | +72.9% | +61.2% | -100.0% |
| YoY Change | — | — | — | -100.0% |